GlassScriptPhysician profile
Shushovan Chakrabortty
NPI 1437164852
$1,246.97
in general payments reported to CMS, 2019-2025
22 companies · $36.83 in 2025
The $36.83 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $187 · 2021: $114 · 2022: $30.92 · 2023: $96.65 · 2024: $40.32 · 2025: $36.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $219.94 | 2019 | |
| Nevro Corp. | $163.93 | 2019 | |
| Flowonix Medical Incorporated | $143.15 | 2019 | |
| Boston Scientific Corporation | $141.56 | 2020-2023 | |
| Stimwave Technologies Incorporated | $118.71 | 2019 | |
| Medtronic, INC. | $74.57 | 2022-2025 | Inceptiv, Synchromedii |
| Abbott Laboratories | $71.95 | 2020-2023 | Proclaim |
| Merck Sharp & Dohme LLC | $43.60 | 2023-2025 | Bridion |
| Grt US Holding, INC. | $31.29 | 2021 | |
| Virtus Pharmaceuticals LLC | $26.06 | 2021 | |
| Averitas Pharma INC. | $25.88 | 2024 | Qutenza |
| Daiichi Sankyo INC. | $25.47 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.94 | 2019-2020 | |
| Nalu Medical, INC. | $21.93 | 2023 | Nalu Neurostimulation System |
| Edwards Lifesciences Corporation | $19.12 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $16.78 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.09 | 2019 | |
| Radius Health, INC. | $13.54 | 2020 | |
| Kaleo, INC. | $12.87 | 2019 | |
| Biodelivery Sciences International, INC. | $12.53 | 2021 | |
| Amgen INC. | $12.14 | 2019 | |
| Horizon Therapeutics Plc | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shushovan Chakrabortty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.